Compare JAZZ & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JAZZ | TLN |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | Ireland | United States |
| Employees | N/A | 1880 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 15.7B |
| IPO Year | 2007 | N/A |
| Metric | JAZZ | TLN |
|---|---|---|
| Price | $248.75 | $371.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 12 |
| Target Price | $217.57 | ★ $432.08 |
| AVG Volume (30 Days) | 789.8K | ★ 922.7K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.43 | N/A |
| Revenue | ★ $1,618,693,000.00 | N/A |
| Revenue This Year | $6.22 | $59.63 |
| Revenue Next Year | $7.68 | $16.08 |
| P/E Ratio | ★ $54.80 | $83.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $105.00 | $300.00 |
| 52 Week High | $250.49 | $451.28 |
| Indicator | JAZZ | TLN |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 46.09 |
| Support Level | $222.49 | $344.30 |
| Resistance Level | $250.49 | $408.61 |
| Average True Range (ATR) | 7.32 | 19.37 |
| MACD | 0.01 | -1.88 |
| Stochastic Oscillator | 89.13 | 29.56 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.